Schematic diagram of precision therapy for three high-risk groups to prevent cancer: (1) those with chronic inflammation, (2) those with inherited germline mutations, and (3) those with precancerous lesions. This idea is the principles for precision cancer prevention.

2-DG inhibits histone lactylation to suppress ESM1 activation, showing anticancer effects on the proliferation, migration, and invasion of HCC cells.